STUDIO

BioStock Studio: Cereno Scientific’s CEO about the milestone in the CS1...

Last week, Spotlight-listed Cereno Scientific got the acceptance from the FDA regarding their IND application for initiating a phase II trial with CS1 in...

BioStock Studio: Immunicum’s CEO on the company’s new therapeutic focus

BioStock Live: World Sepsis Day Seminar with Aptahem

BioStock Studio: Cereno’s CEO is looking forward to trial start

BioStock Studio: CLS’ CEO and VP Clinical Affairs on Q2

Load more

RECOMMENDED READING

Co-founder and CBO Niels Møller Evaxion Biotech

Evaxion Biotech leverages AI to fight cancer and infectious diseases

The development of new medicines is a long and costly process, often associated with...

Iconovo looks to the US where it now meets quality requirements

One of Iconovo's goals is to launch future inhalation products in the US, the...

Market report predicts strong growth for Chordate Medical’s technology

merger

Coegin Pharma fuses with Swedish biotech Follicum

mitokondriell sjukdom

Raising awareness of mitochondrial diseases

Saniona’s new CBO on strategy and business development

EVENT

© BioStock 2021